Sulfamoxole

Chemical structure of Sulfamoxole

Sulfamoxole is a sulfonamide antibiotic used in the treatment of bacterial infections. It is often combined with other antibiotics to enhance its effectiveness. Sulfamoxole works by inhibiting the synthesis of folic acid in bacteria, which is essential for their growth and replication.

Mechanism of Action

Sulfamoxole is a competitive inhibitor of the bacterial enzyme dihydropteroate synthase. This enzyme is involved in the synthesis of dihydrofolic acid, a precursor to folic acid. By inhibiting this enzyme, sulfamoxole prevents bacteria from synthesizing folic acid, which is necessary for the production of nucleic acids and ultimately for bacterial growth and division.

Clinical Uses

Sulfamoxole is primarily used to treat urinary tract infections, respiratory tract infections, and certain types of gastrointestinal infections. It is often used in combination with other antibiotics, such as trimethoprim, to increase its antibacterial spectrum and reduce the likelihood of resistance development.

Side Effects

Common side effects of sulfamoxole include nausea, vomiting, diarrhea, and skin rash. In rare cases, it can cause more serious side effects such as Stevens-Johnson syndrome, toxic epidermal necrolysis, and blood dyscrasias. Patients with a known allergy to sulfonamides should avoid using sulfamoxole.

Pharmacokinetics

Sulfamoxole is well absorbed from the gastrointestinal tract and is widely distributed throughout the body. It is metabolized in the liver and excreted primarily in the urine. The half-life of sulfamoxole allows for dosing every 12 to 24 hours, depending on the severity of the infection and the patient's renal function.

Related Pages

• Sulfonamide (medicine)
• Antibiotic
• Folic acid synthesis inhibitors
• Trimethoprim